New tools and approaches for improved management of inflammatory bowel diseases.

摘要: Abstract Background and aims Inflammatory bowel diseases are part of a wider conglomeration immune-mediated inflammatory diseases. New management approaches need to be developed as we understand more the epidemiology aetiology medical care becomes complex. Methods Selected new tools for improved presented, based on published evidence clinical experience. Results Setting quality standards that consistent across different disease settings will paramount require collaboration between specialist non-specialist centres. Alongside this, value evaluated in terms maximising outcomes over entire cycle patient. In moving towards value-based approach management, it is important determine progression rate by measuring cumulative damage. As well understanding course individual patients, also becoming feasible individualise therapy exploit drug pharmacology achieve better long-term responses. Finally, timely consider formal collaborations specialists ensure cohesive patient care. Conclusions The potential patients with continues increase look when how intervene process adopt collaborative promotes networking reduces heterogeneity settings.